Duchenne muscular dystrophy (DMD) is a genetic disorder characterized by progressive muscle degeneration and weakness due to the alterations of a protein called dystrophin that helps keep muscle cells intact. DMD is one of four conditions known as dystrophinopathies.
Facts About DMD
Duchenne muscular dystrophy (DMD)is the most common form of muscular dystrophy.
It is a genetic disorder characterized by progressive weakness and degeneration of the skeletal muscles that control movement.
affects approximately 1 in 5,000 live male births.
20,000 children are diagnosed with Duchenne globally each year.
DMD is classified as a dystrophinopathy, a muscle disease that results from thr deficiency of a protein called dystrophin.
Treatments Available for DMD:
Emflaza – corticosteroid taken daily
Exondys 51 – used to treat Duchenne in patients who have a confirmed mutation in the dystrophin gene that can be treated by skipping exon 51 intravenous infusion once a week
Amondys, Vyondys, Viltepso – other exon skipping medications give intravenously once weekly
Muscular Dystrophy Clinic at CHM
Multidisciplinary Clinic for neuromuscular problems
Specialist Services include: Neurology, Physical Medicine and Rehabilitation, Pulmonary, Dietician, physical and occupational therapies, community equipment and orthotic services with referrals to endocrinology, cardiology, orthopedics and more
Director of MDA Clinic: Dr. Michelle Figueroa Nurse Coordinator MDA Clinic: Kathleen McMahon, MN, BScN, CPN, RN For appointments call: 313-832-9609 Fax:313-745-3012 for referrals
"This is a dialog window which overlays the main content of the page and plays an embedded YouTube video. Pressing the Close Modal button at the bottom of the modal or pressing the Escape key will close the modal and bring you back to where you were on the page.